QUICKLINKS AND VIEW OPITONS
People given a statin had 25% more new cancers
Monday, May 28, 2018 11:54 am Email this article
People given the statin, pravastatin (Pravachol), had 25% more cancer than those given a placebo in the PROSPER trial.
- 65% more breast cancer
- 46% more gastrointestinal cancer
- 12% more respiratory cancer
- 41% more other cancers
- and they did not including non-melanoma skin cancer.
(Previous studies have found that statins increase the risk of non-melanoma skin cancers.)
Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Meinders AE, Norrie J, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, and Westendorp RG. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet, 2002 Nov 23; 360(9346): 1623-1630.
Author’s Contact Info
University Department of Pathological Biochemistry
University of Glasgow
Scotland, Glasgow, UK
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.